Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Pulse Biosciences Inc
PLSE | US
22.94
USD-0.06
-0.26%
PLSE | US
About Pulse Biosciences Inc
Sector
Healthcare
Industry
Medical Instruments & Supplies
Earnings date
30/06/2024
As of date
06/04/2026
Close
22.94
Open
23.02
High
23.48
Low
22.65
Pulse Biosciences Inc. operates as a novel bioelectric medicine company. It offers CellFX System a tunable software-enabled and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate Inc. and changed its name to Pulse Biosciences Inc. in December 2015. The company was incorporated in 2014 and is headquartered in Hayward California.
View LessPLSE | US
Risk
63.6
Sharpe
0.41
Luna's Score
43/100
Recommendation
Sell
Luna says (PLSE | US)
What's Working
Positive Momentum
What's not Working
Weakness based on declining price with high volume
High 6-Month Volatility (>65%)
Smallcap (300M - 2B USD)
High Market Beta (> 0.8)
Rich in Valuation (Price to Book > 8)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
10 days
80.2%1 month
63.6%3 months
128.3%6 months
96.6%Returns
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
39.32
Debt to equity
0.32
Debt to assets
0.21
Ent. to EBITDA
-1.81
Ent. to rev.
64.63
PEG
-
Other Fundamentals
EBITDA
-44.93M
MarketCap
1.41B
MarketCap(USD)
1.41B
Div. yield
-
Op. margin
-
Erngs. growth
-
Rev. growth
-
Ret. on equity
-100.65
Short ratio
15.85
Short perc.
14.17
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Range10D
4.14
Range1M
5.96
Range3M
13.00
Volumes: Market Activity
Rel. volume
1.17
Price X volume
7.10M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -1.81 | - | Cheaper |
| Ent. to Revenue | 64.63 | - | Expensive |
| PE Ratio | - | 47.18 | - |
| Price to Book | 39.32 | 5.71 | Expensive |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 128.26 | - | Riskier |
| Debt to Equity | 0.32 | 0.92 | Cheaper |
| Debt to Assets | 0.21 | 0.27 | Par |
| Market Cap | 1.41B | - | Emerging |
